Immuneering (IMRX) EBIT Margin (2020 - 2022)
Immuneering's EBIT Margin came in at -3073627.91% for Q4 2022, down 3067764.89 percentage points from -5863.02% a year earlier and down 3039265.87 percentage points from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) EBIT Margin (2020 - 2022) Analysis & Trends
For FY2022, Immuneering's EBIT Margin was -16325.77%, down 14696.61 percentage points from FY2021.
- Going back by year, EBIT Margin was -1629.17% in FY2021 (-890.16 pp) and -739.01% in FY2020.
- The Q4 2022 figure represents the lowest quarterly EBIT Margin in data going back to Q2 2020.
- Year-over-year, EBIT Margin has declined for seven consecutive quarters, with an average year-over-year change of -446322.14 percentage points over the last seven quarters.
- Business Quant data shows IMRX's EBIT Margin at -34362.04% (Q3 2022), -12334.43% (Q2 2022) and -7036.37% (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -3,073,627.91% |
| Sep 30, 2022 | -34,362.04% |
| Jun 30, 2022 | -12,334.43% |
| Mar 31, 2022 | -7,036.37% |
| Dec 31, 2021 | -5,863.02% |
| Sep 30, 2021 | -1,772.01% |
| Jun 30, 2021 | -1,210.67% |
| Mar 31, 2021 | -833.47% |
| Dec 31, 2020 | -877.56% |
| Sep 30, 2020 | -644.66% |
| Jun 30, 2020 | -750.08% |
API Access
Immuneering EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();